Summary
During a press conference in the Oval Office where President Trump discussed a deal to lower drug prices, a drug executive fainted, prompting immediate assistance and a brief interruption of the event. The incident involved Gordon Findlay of Novo Nordisk, with Dr. Mehmet Oz stepping in to help.
Article Content
Oval Office Press Conference Disrupted
On Thursday, a press conference in the Oval Office was cut short when a drug executive collapsed during President Donald Trump's announcement of a deal with pharmaceutical companies to reduce obesity drug prices.
Details of the Event
The event involved President Trump and drugmakers Eli Lilly and Novo Nordisk, focusing on expanding coverage and lowering prices for obesity treatments Zepbound and Wegovy.
Incident with the Executive
While Eli Lilly's CEO, David Ricks, was speaking, he noticed a man, later identified as Gordon Findlay, the global brand director for Novo Nordisk, appearing unwell. Ricks asked, "Are you OK? Gordon, are you OK?"
President Donald Trump observed the scene as Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, intervened when Findlay collapsed to his knees.
Response and Aftermath
Findlay passed out during the event, and security and medical personnel helped him. The press was then asked to leave, and the incident involved high-ranking officials, including the Secretary of Health and Human Services.
Author's summary
This event highlights rapid medical response during a high-profile political announcement, emphasizing the unpredictability of live public events and the need for swift assistance in emergencies.